Professional Documents
Culture Documents
1) Reproducibility
2) Day-to-day reproducibility
3) Standard Curve
4) Correlation
5) Interference testing
To readers of this scientific data
Sysmex corporation
Scientific division
4-4-4 Takatsukadai, Nishi-ku, Kobe 651-2271 JAPAN
Tel : 078-991-1911
Fax : 078-991-1917
E-mail address : scientific@sysmex.co.jp
1
CA-50
Results
Normal Abnormal
pooled plasma Control plasma N Control plasma P
pooled plasma
sec mg/dL sec mg/dL sec mg/dL sec mg/dL
1 9.5 239.4 19.5 109.4 8.6 266.5 22.8 92.3
2 9.6 236.7 19.1 111.9 8.4 273.3 22.5 93.6
3 9.9 229.0 19.1 111.9 8.5 269.8 22.6 93.1
4 9.6 236.7 19.1 111.9 8.5 269.8 23.0 91.4
5 9.7 234.1 18.8 113.8 8.5 269.8 22.8 92.3
6 9.8 231.5 19.0 112.5 8.4 273.3 22.9 91.8
7 9.5 239.4 19.3 110.6 8.4 273.3 23.4 89.7
8 9.7 234.1 19.3 110.6 8.6 266.5 22.6 93.1
9 9.4 242.1 18.6 115.2 8.4 273.3 23.4 89.7
10 9.8 231.5 19.2 111.3 8.5 269.8 23.2 90.5
2
CA-50
Results
1 st 2 nd 3 rd 4 th 5 th Total
1 281.6 285.4 277.9 285.4 274.4
2 277.9 277.9 274.4 281.6 270.9
3 281.6 277.9 274.4 281.6 274.4
4 281.6 277.9 270.9 277.9 277.9
5 285.4 281.6 274.4 277.9 274.4
Mean 281.62 280.14 274.40 280.88 274.40 227.60
SD 2.372 2.995 2.214 2.801 2.214 2.519
CV(%) 0.84 1.07 0.81 1.00 0.81 0.91
(mg/dL)
(mg/dL)
320
Fbg Conc.
300
280
260
240
1 2 3 4 5 (days)
Time
Comment
Ci-Trol Level 1 (normal rage plasma) was measured for Fibrinogen on 5 consecutive days us
ing Thrombin Reagent to test day-to-day reproducibility.
The results were excellent, and CVs 1.00% or less was achieved for each plasma.
3
CA-50
Results
Log.Regress
Log P = a * Log T + b
r = -0.999
a = -1.083E+00
b = 3.437E+00
4
CA-50
Results
CA-50 vs CA-6000
(mg/dL)
600
500
400
CA-50
300
200
y = 0.992x + 8.800
r = 0.994
100
0
0 100 200 300 400 500 600 (mg/dL)
CA-6000
Comment
Correlation of Fibrinogen determination on the CA-50 and the CA-6000 using the Fibrinogen
Determination Reagent in both instruments.
Results were excellent and the correlation was r=0.994 and y=0.992x+8.800.
5
CA-50
Results
(1) Hemoglobin
Hemoglobin conc. (mg/dL) 0 86 172 258 344 430
Measured value (sec) 224.07 217.05 220.51 210.35 220.51 221.69
Interference (%) - -2.9% -1.5% -2.0% -1.5% -1.0%
(2) Lipid
Lipid conc. (Formazine turbidity unit) 0 566 1,132 1,698 2,264 2,830
Measured value (sec) 215.93 221.51 221.69 220.51 226.51 224.07
Interference (%) - 1.9% 2.4% 1.9% 4.3% 3.3%
(3) Conjugated bilirubin
Conjugated bilirubin conc. (mg/dL) 0 4.3 8.6 12.9 17.2 21.5
Measured value (sec) 219.35 221.69 222.87 220.51 225.29 224.07
Interference (%) - 1.0% 1.4% 0.5% 2.4% 1.9%
Comment
Interference of Hemoglobin, Lipid and Conjugated bilirubin in the PT measurement was ex
amined. Various concentration of HemogloinL, Lipid and Conjugated bilirubin were added to
the pooled plasma, which was then assayed for Fibrinogen determination, using Thrombin Re
agent. Hemoglobin made no influence on Fbg result up to 430 mg/dL. Lipid made no influence
on Fbg result up to 2,830 Formazine turbidity unit. Conjugated bilirubin made no influence on
Fbg result up to 21.5 mg/dL.
6
CA-50
Results
(1) Hemoglobin
(sec)
300
Fibrinogen conc.
250
200
150
0 100 200 300 400 500 (mg/dL)
Hemoglobin concentration
(2) Lipid
(sec)
300
Fibrinogen conc.
250
200
150
0 1,000 2,000 3,000
Lipid concentration (Formazine turbidity unit)
250
200
150
0 5 10 15 20 25 (mg/dL)
Conjugated bilirubin concentration